ATTRACT awardee launches new biosensor for Covid-19 research

Several technologies being developed in ATTRACT projects may help fight Covid-19. ATTRACT researchers are exploring their technologies to see how they can be used for early diagnosis and treatment of Covid-19.

AquAffirm launches eChem-Goldtm  thin-film planar gold electrodes for Covid-19 biosensor research 

AquAffirm, an ATTRACT project awardee for the VL4BD and DetectION projects, has launched a range of thin-film planar gold electrodes which are ideal for electrochemistry research associated with Covid-19 biosensor development.

AquAffirm’s thin-film planar gold electrodes are fabricated using high-resolution laser ablation of sputtered gold on a PET substrate with the cell volume delimited by screen-printed hydrophobic ink. Precision manufacture ensures excellent consistency and sensor-to-sensor reproducibility.

With the counter electrode, the working electrode and screen-printed reference electrode made of Ag/AgCl, these electrodes are designed for robust electrochemistry research, with excellent sensor-to-sensor reproducibility a key requirement.

“Together with biomedical/diagnostic applications, these electrodes are ideal for electrochemistry research and analysis in environmental, clinical or agri-food areas and for development of electrochemistry-based biosensors”

Commenting on the project launch, AquAffirm CEO Dr David Sarphie said: “We are delighted to be able to make these precision-manufactured electrodes available for researchers developing new sensors and tests for Covid-19. With the world in desperate need of more rapid, near-patient tests for both the coronavirus antigen and its associated antibodies, we believe these electrodes will prove a useful basis for academic groups and companies developing these tests.”

This article was first published on 28 August by ATTRACT.